Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 27, 2022 - Issue 1
Submit an article Journal homepage
1,364
Views
0
CrossRef citations to date
0
Altmetric
Research Article

β-catenin ISGylation promotes lipid deposition and apoptosis in ethanol-stimulated liver injury models

Qi Dinga Anhui No.2 Provincial People’s Hospital, Hefei, People’s Republic of China
,
Guodong Zhangb School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Yang Wangb School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Lei Xub School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Meifei Wub School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Yiwen Zhoub School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Tao Xub School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Xiaoming Mengb School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
,
Cheng Huangb School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of China
&
Lei Zhangb School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;c Key Laboratory of major autoimmune disease, Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, People’s Republic of China;d The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Anhui Medical University, Hefei, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 239-248 | Published online: 19 Oct 2022

References

  • Alcoholic liver disease. Nat Rev Dis Primers. 2018 Aug 16;4(1):17.
  • Avila MA, Dufour JF, Gerbes AL, et al. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut. 2019 Dec 26;69(4).
  • Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011 Nov;141(5):1572–1585.
  • Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013 Jul;59(1):160–168.
  • Kong LZ, Chandimali N, Han YH, et al. Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. Int J Mol Sci. 2019 Jun 2;20(11):2712.
  • Cheng XY, Liu JD, Lu XY, et al. miR-203 inhibits alcohol-induced hepatic steatosis by targeting Lipin1. Front Pharmacol. 2018;9:275.
  • Apte U, Zeng G, Thompson MD, et al. . beta-catenin is critical for early postnatal liver growth. American Journal of Physiology Gastrointestinal and Liver Physiology. 2007 Jun;292(6):G1578–G1585.
  • Behari J, Sylvester KG. Role of the Wnt/beta-catenin pathway in the pathogenesis of alcoholic liver disease. Curr Mol Pharmacol. 2017;10(3):186–194.
  • Tian L, Shao W, Ip W, et al. The developmental Wnt signaling pathway effector beta-catenin/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism. PLoS Biol. 2019 Oct;17(10):e3000444.
  • Valle-Encinas E, Dale TC. Wnt ligand and receptor patterning in the liver. Curr Opin Cell Biol. 2019 Sep 7;62:17–25.
  • Tan X, Behari J, Cieply B, et al. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology. 2006 Nov;131(5):1561–1572.
  • Lee JH, Bae JA, Lee JH, et al. Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9/CD82 and suppresses the Wnt/beta-catenin signal via ISGylation of beta-catenin. Gut. 2010 Jul;59(7):907–917.
  • Park YS, Kwon YJ, Chun YJ. CYP1B1 activates Wnt/beta-catenin signaling through suppression of Herc5-mediated ISGylation for protein degradation on beta-catenin in HeLa cells. Toxicol Res. 2017 Jul;33(3):211–218.
  • Han HG, Moon HW, Jeon YJ. ISG15 in cancer: beyond ubiquitin-like protein. Cancer Lett. 2018 Dec 1;438:52–62.
  • Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018 Jul;16(7):423–439.
  • Kim YJ, Kim ET, Kim YE, et al. Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators. PLoS Pathog. 2016 Aug;12(8):e1005850.
  • Pelucchi C, Tramacere I, Boffetta P, et al. Alcohol consumption and cancer risk. Nutr Cancer. 2011;63(7):983–990.
  • Gong Z, Tas E, Yakar S, et al. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol. 2017 Nov 5;455:115–130.
  • Liu S, Yeh TH, Singh VP, et al. . beta-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology. 2012 Mar;55(3):931–940.
  • Shi X, Zhao Y, Ding C, et al. Salvianolic acid A alleviates chronic ethanol-induced liver injury via promotion of beta-catenin nuclear accumulation by restoring SIRT1 in rats. Toxicol Appl Pharmacol. 2018 Jul 1;350:21–31.
  • Huang CK, Yu T, de la Monte SM, et al. Restoration of Wnt/beta-catenin signaling attenuates alcoholic liver disease progression in a rat model. J Hepatol. 2015 Jul;63(1):191–198.
  • Hu XY, Hou PF, Li TT, et al. The roles of Wnt/beta-catenin signaling pathway related lncRNAs in cancer. Int J Biol Sci. 2018;14(14):2003–2011.
  • Osborne TF, Espenshade PJ. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. Genes Dev. 2009 Nov 15;23(22):2578–2591.
  • Ma HY, Yamamoto G, Xu J, et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J Hepatol. 2019 Dec 31;72(5):946–959.
  • Lu C, Zhang F, Xu W, et al. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes. IUBMB Life. 2015 Aug;67(8):645–658.
  • Crabb DW, Liangpunsakul S. Alcohol and lipid metabolism. J Gastroenterol Hepatol. 2006 Oct;21(Suppl 3):S56–S60.
  • Szabo G, Petrasek J. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol Alcohol. 2017 Jul 1;52(4):414–424.
  • Bluemel S, Williams B, Knight R, et al. Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. American Journal of Physiology Gastrointestinal and Liver Physiology. 2016 Dec 1;311(6):G1018–G1036.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.